Penumbra (PEN) shares were up more than 11% in recent Wednesday trading following its better-than-expected Q2 results and an increase in its revenue guidance in the previous day.
"PEN delivered a Q2 beat, and raised 2025 guidance based on
strong peripheral vascular growth and above market growth in stroke," RBC analysts said in a note.
"We believe business momentum at PEN is robust," they added.
RBC reaffirmed its outperform rating while lowering its price target to $325 from $330.
Separately, UBS raised its price target to $335 from $330, and Truist raised its price target to $310 from $300.
More than 736,000 shares were traded, compared with an average volume of about 486,000.
Price: 253.12, Change: +25.97, Percent Change: +11.43
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。